跳至主要内容
临床试验/NCT02396732
NCT02396732终止4 期

The Role Of Combined Therapy With Aspirin and Enoxaparin In Prevention Of Venous Thromboembolism In Trauma Patients: A Randomized-Controlled Trial

University of Miami1 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2016年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
终止
入组人数
31
试验地点
1
主要终点
Incidence of Venous Thromboembolism

研究概览

简要总结

The purpose of this study is to determine if the addition of antiplatelet therapy (i.e. aspirin) to low-molecular-weight-heparin (i.e. enoxaparin) will decrease the incidence of venous thromboembolism (VTE) in high-risk critically injured patients. The investigators further aim to determine the safety and efficacy of dual thromboprophylaxis with aspirin and enoxaparin for decreasing the incidence of VTE after trauma.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 years or older
  • Blunt or penetrating trauma
  • Requires VTE thromboprophylaxis
  • High-risk for VTE

排除标准

  • Presence of VTE upon admission
  • Pregnant or nursing
  • Inability to give informed consent by patient or healthcare proxy
  • Contraindication to enoxaparin
  • Contraindication to aspirin
  • Epidural or subdural hematoma
  • Presence, or removal within the last 12 hours, of an epidural or spinal catheter, or recent (within the last 12 hours) epidural or spinal anesthesia/procedures

研究组 & 干预措施

Low Molecular Weight Heparin (LMWH) + Aspirin (ASA)

Experimental

Group will get both enoxaparin (standard of care) and aspirin (intervention) after consent up to Intensive Care Unit (ICU) discharge.

干预措施: Aspirin (Drug)

Low Molecular Weight Heparin (LMWH) + Aspirin (ASA)

Experimental

Group will get both enoxaparin (standard of care) and aspirin (intervention) after consent up to Intensive Care Unit (ICU) discharge.

干预措施: Enoxaparin (Drug)

Low Molecular Weight Heparin (LMWH) Alone

Active Comparator

Group will get only enoxaparin (standard of care) after consent up to Intensive Care Unit (ICU) discharge.

干预措施: Enoxaparin (Drug)

结局指标

主要结局

Incidence of Venous Thromboembolism

时间窗: Up to 2 months of hospitalization

Incidence of VTE is defined as new cases reported of: 1. Deep Vein Thrombosis (DVT), symptomatic or asymptomatic as assessed via venous duplex ultrasonography, and 2. Pulmonary Embolism (PE), symptomatic or asymptomatic as assessed via chest computed tomography with angiography (CTA) or ventilation-perfusion (VQ) Scan

次要结局

  • Change in Hypercoagulability(Baseline, up to 2 months hospitalization)
  • Mortality(Up to 2 months of hospitalization)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kenneth Proctor

Professor of Surgery

University of Miami

研究点 (1)

Loading locations...

相似试验